rs11658164
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 1P and 9B. PP2BP4_StrongBP6BS2
The NM_017534.6(MYH2):āc.3127T>Gā(p.Ser1043Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00192 in 1,614,128 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S1043F) has been classified as Likely benign.
Frequency
Consequence
NM_017534.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYH2 | NM_017534.6 | c.3127T>G | p.Ser1043Ala | missense_variant | 25/40 | ENST00000245503.10 | |
MYHAS | NR_125367.1 | n.168-38065A>C | intron_variant, non_coding_transcript_variant | ||||
MYH2 | NM_001100112.2 | c.3127T>G | p.Ser1043Ala | missense_variant | 25/40 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYH2 | ENST00000245503.10 | c.3127T>G | p.Ser1043Ala | missense_variant | 25/40 | 1 | NM_017534.6 | P1 | |
ENST00000399342.6 | n.207-3852A>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00126 AC: 192AN: 152120Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00118 AC: 296AN: 251352Hom.: 2 AF XY: 0.00117 AC XY: 159AN XY: 135850
GnomAD4 exome AF: 0.00199 AC: 2910AN: 1461890Hom.: 7 Cov.: 34 AF XY: 0.00192 AC XY: 1395AN XY: 727246
GnomAD4 genome AF: 0.00126 AC: 192AN: 152238Hom.: 1 Cov.: 32 AF XY: 0.00117 AC XY: 87AN XY: 74438
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | MYH2: PP3, BS2 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 22, 2015 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2020 | This variant is associated with the following publications: (PMID: 25617006) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Nov 17, 2020 | - - |
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Aug 11, 2020 | - - |
MYH2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 17, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Myopathy, proximal, and ophthalmoplegia Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at